Yes the buying late this week was strong and strategic. The...

Yes the buying late this week was strong and strategic. The buyers took a bite and then sat back and allowed the sell side to replenish before taking another parcel - great ‘rope a dope’ buying strategy that will help to tighten the register.
The buying looks like more than someone getting in for the next announcement and flipping.
We know the Nerve announcement will be good and it is due this month. There is also the growing potential for a significant partnership announcement that could be dropped at anytime - and then hold your hats.
The third and fourth quarters will also see highly significant end points to trials and possible FDA and TGA progression and approvals on a number products.

The ground work has been built over a number of years, the product inventory is best in class, the next six months will see a significant relate.
My biggest concern is a left field low ball takeover offer come in before we see OCC’s true potential realised.